NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

vTv Therapeutics Inc (NASDAQ: VTVT)

 
VTVT Technical Analysis
3
As on 9th Jun 2023 VTVT STOCK Price closed @ 0.80 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.82 & Sell for SHORT-TERM with Stoploss of 0.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VTVTSTOCK Price

Open 0.82 Change Price %
High 0.85 1 Day 0.00 0.00
Low 0.80 1 Week -0.06 -6.98
Close 0.80 1 Month 0.07 9.59
Volume 46800 1 Year -0.27 -25.23
52 Week High 1.37 | 52 Week Low 0.39
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VTVT
Daily Charts
VTVT
Intraday Charts
Whats New @
Bazaartrend
VTVT
Free Analysis
 
VTVT Important Levels Intraday
RESISTANCE0.90
RESISTANCE0.87
RESISTANCE0.85
RESISTANCE0.83
SUPPORT0.77
SUPPORT0.75
SUPPORT0.73
SUPPORT0.70
 
VTVT Forecast May 2024
4th UP Forecast1.47
3rd UP Forecast1.26
2nd UP Forecast1.12
1st UP Forecast0.99
1st DOWN Forecast0.61
2nd DOWN Forecast0.48
3rd DOWN Forecast0.34
4th DOWN Forecast0.13
 
VTVT Weekly Forecast
4th UP Forecast1.20
3rd UP Forecast1.07
2nd UP Forecast0.99
1st UP Forecast0.91
1st DOWN Forecast0.69
2nd DOWN Forecast0.61
3rd DOWN Forecast0.53
4th DOWN Forecast0.40
 
VTVT Forecast2024
4th UP Forecast2.77
3rd UP Forecast2.14
2nd UP Forecast1.75
1st UP Forecast1.36
1st DOWN Forecast0.24
2nd DOWN Forecast-0.15
3rd DOWN Forecast-0.54
4th DOWN Forecast-1.17
 
 
VTVT Other Details
Segment EQ
Market Capital 117435792.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VTVT Address
VTVT
 
VTVT Latest News
 
Your Comments and Response on vTv Therapeutics Inc
 
VTVT Business Profile
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant PDE4 inhibitor that addresses inflammatory diseases. It is also involved in the clinical development of other programs, including a small molecule GLP-1r agonist; the PDE4 inhibitor; HPP737, a PPAR-delta agonist; and an Nrf2 activator through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; Novo Nordisk A/S; and Columbia University. The company was founded in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated. Address: 3980 Premier Drive, High Point, NC, United States, 27265
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service